Biotech emerges as newBiotech emerges as new US-China battleground
US and Chinese ties are facing fresh strain as biotechnology is pulled into the wider technology rivalry between the two countries, according to reporting from June 2.
The debate centers on whether new US measures could slow cross-border deals and reshape access to Chinese drug candidates, which matters because biotech is becoming a strategic industry as well as a commercial one.
US policy perspective
Supporters of tighter rules see biotech as part of a broader effort to limit strategic dependence on China in sensitive sectors. They argue that investment screening and related measures are meant to protect national security and key supply chains.
Industry and academic perspective
Critics warn that the new focus could discourage American companies from buying Chinese drug candidates and reduce cooperation that has helped move medicines forward. They say the rules may create uncertainty for firms that rely on cross-border research and licensing.
- China has become one of the world’s largest hubs for early-stage drug discovery.
- Many modern medicines are first developed through partnerships that span several countries.
- Biotech investment can affect both public health and industrial policy at the same time.
US-China Indo-Pacific Rivalry
China and Taiwan coast guard vessels have repeatedly faced off near the Pratas Islands, with the latest standoff showing how small maritime incidents around Taiwan can quickly become confrontations.[1][5] The episode adds to wider U.S.-China military tension across the Indo-Pacific, where Beijing is expanding patrols and Washington is reinforcing regional deterrence.[2][3] The rivalry now centers on preventing miscalculation around Taiwan, the South China Sea, and nearby sea lanes.[1][3][5] It also shapes defense planning by Taiwan, Japan, the Philippines, and the United States as all sides weigh coercion, sovereignty claims, and the risk of escalation.[2][3]
24 May, 07:39 AM
Taiwan and China coast guards face off near Pratas islands1 January
The United States adopts a sharper great-power competition strategy focused on China
